Advanced Search

Fibroblast Growth Factor Receptor Stocks List

Symbol Grade Name % Change
BPMC D Blueprint Medicines Corporation -5.84
NGM C NGM Biopharmaceuticals, Inc. 4.04
BBIO C BridgeBio Pharma, Inc. -3.43
FUSN F Fusion Pharmaceuticals Inc. -0.51
RLAY F Relay Therapeutics, Inc. -2.72
KNTE F Kinnate Biopharma Inc. 3.35
View As Page of Charts
Related Industries: Biotechnology
Related Stock Lists: Fibroblast Growth Factor Tyrosine Kinase Receptors Solid Tumors Tyrosine Kinase Biopharmaceutical Cancer Cell Biology Clinical Development Insulin Precision Medicine Protein Kinase Inhibitor Achondroplasia Advanced Solid Tumors Age Related Macular Degeneration Alcohol Amyloid Amyloidosis Anatomy Antibodies Biopharmaceuticals

Related ETFs - A few ETFs which own one or more of the above listed Fibroblast Growth Factor Receptor stocks.

Symbol Grade Name Weight
LRNZ D TrueMark Technology, AI & Deep Learning ETF 3.85
IDNA D iShares Genomics Immunology and Healthcare ETF 3.64
IBBJ F Defiance Nasdaq Junior Biotechnology ETF 3.52
GNOM D Global X Genomics & Biotechnology ETF 2.94
SBIO D ALPS Medical Breakthroughs ETF 2.93
View all Fibroblast Growth Factor Receptor related ETFs...
Compare ETFs
  • Compare IDNA to IBBJ
  • Compare LRNZ to GNOM
  • Compare LRNZ to SBIO

    • Recent Signals

    Date Stock Signal Type
    2021-03-03 BBIO 20 DMA Resistance Bearish
    2021-03-03 BBIO MACD Bearish Signal Line Cross Bearish
    2021-03-03 BBIO 50 DMA Resistance Bearish
    2021-03-03 BPMC 20 DMA Resistance Bearish
    2021-03-03 FUSN 20 DMA Resistance Bearish
    2021-03-03 FUSN 50 DMA Resistance Bearish
    2021-03-03 FUSN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
    2021-03-03 KNTE 20 DMA Resistance Bearish
    2021-03-03 NGM MACD Bullish Centerline Cross Bullish
    2021-03-03 NGM Crossed Above 50 DMA Bullish
    2021-03-03 NGM Crossed Above 20 DMA Bullish

    Recent News for Fibroblast Growth Factor Receptor Stocks

    Date Stock Title
    Mar 3 KNTE Kinnate Biopharma (KNTE) Investor Presentation - Slideshow
    Mar 3 BPMC Blueprint says EMA validated Ayvakyt marketing application for systemic mastocytosis
    Mar 3 BPMC Blueprint Medicines Announces EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
    Mar 3 KNTE We're Hopeful That Kinnate Biopharma (NASDAQ:KNTE) Will Use Its Cash Wisely
    Mar 2 FUSN Fusion to buy Ipsen's IPN-1087 in pipeline expansion push
    Mar 2 NGM NGM Bio starts dosing in early-stage pancreatic cancer study
    Mar 2 NGM NGM Bio Initiates Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120 in Patients with Metastatic Pancreatic Cancer
    Mar 2 FUSN Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
    Mar 1 BBIO BridgeBio Jumps 6% Pre-Market On FDA Approval For Nulibry
    Mar 1 BBIO BridgeBio Pharma Gets First FDA-Approval For Rare Genetic Metabolic Disorder
    Mar 1 BBIO FDA OKs BridgeBio Pharma's Nulibry in severe neurologic damage
    Feb 28 BBIO BridgeBio Pharma and Affiliate Origin Biosciences Announce FDA Approval of NULIBRY™ (fosdenopterin), the First and Only Approved Therapy to Reduce the Risk of Mortality in Patients with MoCD Type A
    Feb 27 BPMC 15 Fastest Growing Biotech Companies in the US
    Feb 27 RLAY Relay Therapeutics: A Long-Term Position In Data-Driven Drug Developer Looks Attractive
    Feb 26 BBIO Is a Surprise Coming for BridgeBio Pharma (BBIO) This Earnings Season?
    Feb 25 NGM NGM Bio to Present at the Cowen 41st Annual Health Care Conference
    Feb 25 BBIO BridgeBio Pharma EPS misses by $0.16, misses on revenue
    Feb 25 BBIO BridgeBio Pharma, Inc. Reports Fourth Quarter And Full Year 2020 Financial Results And Business Update
    Related Industries: Biotechnology
    Related Stock Lists: Fibroblast Growth Factor Tyrosine Kinase Receptors Solid Tumors Tyrosine Kinase Biopharmaceutical Cancer Cell Biology Clinical Development Insulin Precision Medicine Protein Kinase Inhibitor Achondroplasia Advanced Solid Tumors Age Related Macular Degeneration Alcohol Amyloid Amyloidosis Anatomy Antibodies Biopharmaceuticals

    Browse All Tags